BRPI0408699A - uso de compostos para a prevenção de toxicidade celular fármaco-induzida - Google Patents
uso de compostos para a prevenção de toxicidade celular fármaco-induzidaInfo
- Publication number
- BRPI0408699A BRPI0408699A BRPI0408699-6A BRPI0408699A BRPI0408699A BR PI0408699 A BRPI0408699 A BR PI0408699A BR PI0408699 A BRPI0408699 A BR PI0408699A BR PI0408699 A BRPI0408699 A BR PI0408699A
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- cellular toxicity
- prevention
- induced
- drug
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 6
- 230000007541 cellular toxicity Effects 0.000 title abstract 5
- 239000003814 drug Substances 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 231100000167 toxic agent Toxicity 0.000 abstract 3
- 238000011282 treatment Methods 0.000 abstract 3
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 abstract 1
- 229930182566 Gentamicin Natural products 0.000 abstract 1
- 102000001846 Low Density Lipoprotein Receptor-Related Protein-2 Human genes 0.000 abstract 1
- 108010015372 Low Density Lipoprotein Receptor-Related Protein-2 Proteins 0.000 abstract 1
- 206010029155 Nephropathy toxic Diseases 0.000 abstract 1
- 206010033109 Ototoxicity Diseases 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 abstract 1
- 229960002518 gentamicin Drugs 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 231100000417 nephrotoxicity Toxicity 0.000 abstract 1
- 230000007694 nephrotoxicity Effects 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 231100000262 ototoxicity Toxicity 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200300459 | 2003-03-26 | ||
| PCT/DK2004/000205 WO2004084876A2 (en) | 2003-03-26 | 2004-03-25 | Use of compounds for the prevention of drug-induced cell toxicity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0408699A true BRPI0408699A (pt) | 2006-03-28 |
Family
ID=58707224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0408699-6A BRPI0408699A (pt) | 2003-03-26 | 2004-03-25 | uso de compostos para a prevenção de toxicidade celular fármaco-induzida |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20070004727A1 (https=) |
| EP (1) | EP1610773A2 (https=) |
| JP (1) | JP2006520761A (https=) |
| CN (1) | CN100441175C (https=) |
| AU (1) | AU2004224788A1 (https=) |
| BR (1) | BRPI0408699A (https=) |
| CA (1) | CA2560522A1 (https=) |
| EA (1) | EA200501518A1 (https=) |
| MX (1) | MXPA05010143A (https=) |
| WO (1) | WO2004084876A2 (https=) |
| ZA (1) | ZA200508482B (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006037335A2 (en) * | 2004-10-06 | 2006-04-13 | Recepticon Aps | Use of compounds for the prevention of drug-induced cell toxicity |
| US8080645B2 (en) | 2007-10-01 | 2011-12-20 | Longhorn Vaccines & Diagnostics Llc | Biological specimen collection/transport compositions and methods |
| US9481912B2 (en) | 2006-09-12 | 2016-11-01 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for detecting and identifying nucleic acid sequences in biological samples |
| US8097419B2 (en) | 2006-09-12 | 2012-01-17 | Longhorn Vaccines & Diagnostics Llc | Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009 |
| WO2008113364A2 (en) * | 2007-03-20 | 2008-09-25 | Recepticon Aps | Amino derivatives to prevent nephrotoxicity and cancer |
| US9683256B2 (en) | 2007-10-01 | 2017-06-20 | Longhorn Vaccines And Diagnostics, Llc | Biological specimen collection and transport system |
| US11041215B2 (en) | 2007-08-24 | 2021-06-22 | Longhorn Vaccines And Diagnostics, Llc | PCR ready compositions and methods for detecting and identifying nucleic acid sequences |
| US10004799B2 (en) | 2007-08-27 | 2018-06-26 | Longhorn Vaccines And Diagnostics, Llc | Composite antigenic sequences and vaccines |
| AU2008293504B2 (en) | 2007-08-27 | 2012-04-12 | Longhorn Vaccines & Diagnostics, Llc | Immunogenic compositions and methods |
| US11041216B2 (en) | 2007-10-01 | 2021-06-22 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples |
| CA2861667C (en) | 2007-10-01 | 2017-06-13 | Longhorn Vaccines And Diagnostics, Llc | Biological specimen collection and transport system and methods of use |
| WO2012151555A1 (en) * | 2011-05-04 | 2012-11-08 | President And Fellows Of Harvard College | Methods and coatings for treating biofilms |
| WO2013112916A1 (en) | 2012-01-26 | 2013-08-01 | Longhorn Vaccines And Diagnostics, Llc | Composite antigenic sequences and vaccines |
| WO2016183292A1 (en) | 2015-05-14 | 2016-11-17 | Longhorn Vaccines And Diagnostics, Llc | Rapid methods for the extraction of nucleic acids from biological samples |
| WO2020108753A1 (en) * | 2018-11-28 | 2020-06-04 | ITM Isotopen Technologien München AG | Novel tumor antigen binding agents and uses thereof |
| CN115003311B (zh) * | 2019-12-14 | 2024-04-19 | 乔杜里·马努 | 降低多器官毒性的多元药物制剂 |
| JP2024506999A (ja) * | 2021-02-02 | 2024-02-15 | コン，ヤンピン | がんを処置するための組成物および方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1364521A (en) * | 1971-07-16 | 1974-08-21 | Merck & Co Inc | Aminoglycoside antibiotics |
| US4564325A (en) * | 1983-03-14 | 1986-01-14 | Ackerman Galen R | Flush-mounted round bale mover for truck beds |
| US4654325A (en) * | 1984-05-24 | 1987-03-31 | Selenke William M | Medicament for reducing nephrotoxicity caused by positively charged agents such as aminoglycosides and methods of use thereof |
| AU629533B2 (en) * | 1987-12-22 | 1992-10-08 | U.S. Bioscience, Inc. | Improving toxicity profiles in chemotherapy |
| US5010092A (en) * | 1989-12-22 | 1991-04-23 | Wisconsin Alumni Research Foundation | Protection against chemically-induced kidney damage by methimazole |
| US5039666A (en) * | 1990-10-30 | 1991-08-13 | Hoechst-Roussel Pharmaceuticals Inc. | Aminoglycoside composition having substantially reduced nephrotoxicity induced by the aminoglycoside |
| US5409915A (en) * | 1993-09-14 | 1995-04-25 | The University Of Vermont And State Agricultural College | Bis-platinum (IV) complexes as chemotherapeutic agents |
| US5658902A (en) * | 1994-12-22 | 1997-08-19 | Warner-Lambert Company | Quinazolines as inhibitors of endothelin converting enzyme |
| US6130217A (en) * | 1995-09-20 | 2000-10-10 | Pfizer Inc | Compounds enhancing antitumor activity of other cytotoxic agents |
| WO1999002145A1 (en) * | 1997-07-07 | 1999-01-21 | Cambridge Neuroscience, Inc. | Combination drug therapies comprising aminoglycoside antibiotics and n,n'-disubstituted guanidines |
| US6177434B1 (en) * | 1997-12-16 | 2001-01-23 | The United States Of America As Represented By The Secretary Of The Navy | Prevention or reversal of sensorineural hearing loss (SNHL) through biologic mechanisms |
| US6949679B1 (en) * | 1998-04-21 | 2005-09-27 | Universite Laval | Polyamine transport inhibitors |
| FR2797444B1 (fr) * | 1999-08-13 | 2003-02-07 | Lafon Labor | Compositions pharmaceutiques comprenant des 4-quinolones |
| DE10053506A1 (de) * | 2000-10-27 | 2002-05-02 | Max Delbrueck Centrum | Mittel zur Prävention von Organschäden, die durch Aminoglykoside induziert werden |
| CN100582084C (zh) * | 2001-01-08 | 2010-01-20 | 麦迪凯斯特治疗学股份有限公司 | 疏水性多胺类似物及其使用方法 |
| US20050027016A1 (en) * | 2002-02-07 | 2005-02-03 | Fahl Kathleen L | Polyamine compounds and compositions for use in conjection with cancer therapy |
| AU2002307802A1 (en) * | 2002-04-25 | 2003-10-08 | Recepticon Aps | Antagonists of megalin or cubilin for use in preventing organ damage induced by therapeutic agents |
-
2004
- 2004-03-25 ZA ZA200508482A patent/ZA200508482B/xx unknown
- 2004-03-25 EA EA200501518A patent/EA200501518A1/ru unknown
- 2004-03-25 AU AU2004224788A patent/AU2004224788A1/en not_active Abandoned
- 2004-03-25 EP EP04723168A patent/EP1610773A2/en not_active Withdrawn
- 2004-03-25 BR BRPI0408699-6A patent/BRPI0408699A/pt not_active Application Discontinuation
- 2004-03-25 WO PCT/DK2004/000205 patent/WO2004084876A2/en not_active Ceased
- 2004-03-25 CA CA002560522A patent/CA2560522A1/en not_active Abandoned
- 2004-03-25 CN CNB2004800146578A patent/CN100441175C/zh not_active Expired - Fee Related
- 2004-03-25 JP JP2006504337A patent/JP2006520761A/ja not_active Withdrawn
- 2004-03-25 US US10/550,488 patent/US20070004727A1/en not_active Abandoned
- 2004-03-25 MX MXPA05010143A patent/MXPA05010143A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200508482B (en) | 2007-03-28 |
| WO2004084876A3 (en) | 2004-12-23 |
| US20070004727A1 (en) | 2007-01-04 |
| EP1610773A2 (en) | 2006-01-04 |
| CA2560522A1 (en) | 2004-10-07 |
| AU2004224788A1 (en) | 2004-10-07 |
| WO2004084876A2 (en) | 2004-10-07 |
| JP2006520761A (ja) | 2006-09-14 |
| MXPA05010143A (es) | 2006-03-17 |
| EA200501518A1 (ru) | 2006-04-28 |
| CN100441175C (zh) | 2008-12-10 |
| CN1794982A (zh) | 2006-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0408699A (pt) | uso de compostos para a prevenção de toxicidade celular fármaco-induzida | |
| WO2008113364A3 (en) | Amino derivatives to prevent nephrotoxicity and cancer | |
| BRPI0608840B8 (pt) | composição farmacêutica compreendendo uma difenil uréia substituída por ômega-carboxiarila, e seu processo de preparação | |
| BRPI0509172A (pt) | pelo menos uma entidade quìmica, composição farmacêutica, métodos para tratar um paciente, para inibir pelo menos uma enzima que utiliza atp, e para tratar pelo menos uma doença, uso de pelo menos uma entidade quìmica, e, método para a fabricação de um medicamento | |
| BR0312464A (pt) | Inibidores de tirosina quinases | |
| BRPI0718803B8 (pt) | composto para inibir a progressão mitótica, composição farmacêutica e método in vitro para inibir a atividade de aurora cinase em uma célula | |
| BRPI0507236A (pt) | método para o tratamento ou profilaxia de uma condição, e, composto | |
| WO2006010557A8 (de) | D-glucopyranosyl-phenyl-substituierte cyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung | |
| AP2001002232A0 (en) | Imidazole derivatives | |
| MX2007002398A (es) | Nuevas composiciones farmaceuticas para el tratamiento de cancer. | |
| DE60210752D1 (de) | Pharmazeutische zusammensetzung enthaltend proteoglykan und ihre verwendung zur behandlung von entzündlichen erkrankungen | |
| WO2006102610A3 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
| BR0306785A (pt) | Deazapurinas e seus usos | |
| WO2006099941A8 (de) | Aminocarbonyl substituierte 8-n-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| BRPI0519700A2 (pt) | misturas fungicidas, agente, processo para combater fungos nocivos fitopatogênicos, semente, uso dos compostos | |
| BRPI0714761B8 (pt) | formulações compreendendo compostos cíclicos | |
| WO2007014619A8 (en) | Novelimidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same | |
| TR199801935T2 (xx) | N�trofil elastaz inhibit�rleri olarak pirolopirolon t�revleri. | |
| PE103799A1 (es) | Procedimiento de purificacion de mesilato de alatrofloxacino | |
| BR0008302A (pt) | Uso de um derivado de benzaldeìdo, derivado de benzaldeìdo, composição farmacêutica, e, processo para a fabricação da mesma | |
| WO2006037335A3 (en) | Use of compounds for the prevention of drug-induced cell toxicity | |
| WO2007024843A3 (en) | Pyrimidinyl-pyrazole inhibitors of aurora kinases | |
| BRPI0407968A (pt) | derivados de oxamida úteis como inibidores de raf-quinase | |
| BRPI0519698A2 (pt) | misturas fungicidas, agente, processo para combater fungos nocivos fitopatogênicos, semente, e, uso dos compostos | |
| PT1213972E (pt) | Composicao compreendendo um inibidor da alfa-amilase e pelo menos um composto fisiologicamente aceitavel capaz de reduzir a absorcao intestinal dos "acucares rapidos" |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |